Daptomycin Injection, Powder, Lyophilized, For Solution
Product Images NDC 67457-941

2 FDA label images from Mylan Institutional Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Daptomycin (NDC 67457-941). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Institutional Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Daptomycin Structural Formula (Image 02)

Daptomycin Structural Formula (Image 02)
Label for Daptomycin for Injection 500 mg per vial, a lyophilized powder for intravenous use. The label includes storage instructions to keep the product between 20° to 25°C and directs users to see the package insert for reconstitution details. It is manufactured for Mylan Institutional LLC, Morgantown, WV, and made in India. The vial is single-dose and sterile.*
FDA Label Image

Daptomycin For Injection 500 mg Carton Label (Image 01)

Daptomycin For Injection 500 mg Carton Label (Image 01)
Chemical structure of daptomycin, the active ingredient in the injection, powder, lyophilized, for solution product by Mylan Institutional LLC.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.